Soluble expression of human DRR1 (down-regulated in renal cell carcinoma 1) in Escherichia coli and preparation of its polyclonal antibodies.

Xin-Yu Zhao,Hong-Xia Li,Shu-Fang Liang,Zhu Yuan,Fei Yan,Xu-Zhi Ruan,Jia You,Shao-Quan Xiong,Ming-Hai Tang,Yu-Quan Wei

DOI: https://doi.org/10.1042/BA20070027

2008-01-01

Biotechnology and Applied Biochemistry

Abstract:Human DRRI (down-regulated in renal cell carcinoma 1) is widely expressed in normal tissues but dramatically reduced or even undetectable in a number of differ ent cancer cell lines and primary tumour types. DRR I from Homo sapiens was cloned into the pQE30 vector for fusion-protein expression with six histidine residues in Escherichia coli BL2I (DE3). A soluble protein with a molecular mass of approx. 19 kDa on SDS/PAGE that matches the expected rDRRI (recombinant DRRI) molecular mass (18.7 kDa) was obtained. The soluble and insoluble expression of recombinant protein DRR I (rDRRI) was temperature-dependent. The expression rDRR I was in soluble and insoluble forms at 37 degrees C, and approx. 80 % of total rDRR I was soluble at 37 degrees C, while rDRRI was almost exclusively expressing in soluble form at 20 degrees C. The expressed rDRRI at 20 degrees C was affinity-purified on Ni2+-charged resin under native conditions. The purified protein was further identified by ESI-MS(electrospray ionization MS). The purified recombinant protein rDRRI was further used to raise anti-(human DRRI) polyclonal antibodies, which were suitable for detecting both the recombinant exogenous DRRI and the endogenous DRRI from tissues and cells by immunoblotting and immunohistochemistry. The purified rDRRI and our prepared anti-(human DRRI) polyclonal antibodies may provide useful tools for future biological function studies on DRRI.